Antihypertensive drugs and risk of COVID-19?

被引：15
|
作者：
Lo, Kevin Bryan [1 ]
McCullough, Peter A. [2 ]
Rangaswami, Janani [1 ]
机构：
[1] Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA
[2] Baylor Heart & Vasc Inst, Dallas, TX USA
来源：
LANCET RESPIRATORY MEDICINE | 2020年 / 8卷 / 05期
关键词：
D O I：
10.1016/S2213-2600(20)30156-9
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：E29 / E29
页数：1
相关论文
共 50 条
  • [1] Antihypertensive drugs and risk of COVID-19? Reply
    Fang, Lei
    Karakiulakis, George
    Roth, Michael
    LANCET RESPIRATORY MEDICINE, 2020, 8 (05): : E32 - E33
  • [2] Antihypertensive drugs and COVID-19
    Henry, David
    HEART, 2021, 107 (01)
  • [3] Antihypertensive drugs in COVID-19 infection
    Pinto-Sietsma, Sara-Joan
    Flossdorf, Michael
    Buchholz, Veit R.
    Offerhaus, Joost
    Bleijendaal, Hidde
    Beudel, Martijn
    Volders, Paul G. A.
    ter Bekke, Rachel M. A.
    Dormans, Tom
    Zwetsloot, Peter-Paul
    de Jager, Peter
    Massberg, Steffen
    Raemer, Patrick
    Wendtner, Clemens
    Hoffmann, Ellen
    Rothe, Kathrin
    Feihl, Susanne
    Kessler, Thorsten
    Pinto, Yigal M.
    Schunkert, Heribert
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (06) : 415 - 416
  • [4] Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis
    Ren, Lu
    Yu, Shandong
    Xu, Wilson
    Overton, James L.
    Chiamvimonvat, Nipavan
    Thai, Phung N.
    JOURNAL OF CARDIOLOGY, 2021, 77 (05) : 482 - 491
  • [5] Antihypertensive Drugs and COVID-19 Risk A Cohort Study of 2 Million Hypertensive Patients
    Semenzato, Laura
    Botton, Jeremie
    Drouin, Jerome
    Baricault, Berangere
    Vabre, Clementine
    Cuenot, Francois
    Penso, Laetitia
    Herlemont, Philippe
    Sbidian, Emilie
    Weill, Alain
    Dray-Spira, Rosemary
    Zureik, Mahmoud
    HYPERTENSION, 2021, 77 (03) : 833 - 842
  • [6] 5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19
    Fekete, Thomas
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : JC35 - JC35
  • [7] Antihypertensive drugs and COVID-19-Reply
    Hippisley-Cox, Julia
    Tan, Pui San
    Coupland, Carol
    HEART, 2021, 107 (01) : 85 - 86
  • [8] Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs
    Ruilope, Luis M.
    Tamargo, Juan
    Ruiz-Hurtado, Gema
    EUROPEAN HEART JOURNAL, 2020, 41 (22) : 2067 - 2069
  • [9] Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
    Laurent Chouchana
    Nathanaël Beeker
    Nicolas Garcelon
    Bastien Rance
    Nicolas Paris
    Elisa Salamanca
    Elisabeth Polard
    Anita Burgun
    Jean-Marc Treluyer
    Antoine Neuraz
    Cardiovascular Drugs and Therapy, 2022, 36 : 483 - 488
  • [10] Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
    Chouchana, Laurent
    Beeker, Nathanael
    Garcelon, Nicolas
    Rance, Bastien
    Paris, Nicolas
    Salamanca, Elisa
    Polard, Elisabeth
    Burgun, Anita
    Treluyer, Jean-Marc
    Neuraz, Antoine
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 483 - 488
12345